1S THURET, L D F MOON, F H GAGE. Therapeutic interven- tions after spinal cord injury[J]. Nature Reviews, 2006, 7: 628 - 643.
2LU J, WAYIE P. Spine update: advances in spinal cord re- generation[J]. Spine, 1999, 24: 926-930.
3KWON B K, TETZLAFF W, GRAUER J N, et al. Pathophy- siology and pharmacologic treatment of acute spinal cord injury [J]. Spine J, 2004, 4(4) : 451 - 464.
4AMBROZAITIS K V, KONTAUTAS E, SPAKAUSKAS B, et al. Pathophysiology of acute spinal cord injury[J]. Medicina (Kaunas), 2006, 42(3): 255- 261.
5PARK E, VELUMIAN A A, FEHI2NGS M G, et al. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration[J]. J Neurotrauma, 2004, 21(6): 754-774.
6MCGEE A W, STRITTMATTER S M. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration[J]. Trends Neurosci, 2003, 26(4) : 193 - 198.
7WALMSLEY A R, MIR A K. Targeling the Nogo-A signalling pathway to promote recovery following acute CNS [ J ]. Curr Phann Des, 2007, 13(24) : 2470- 2484.
8PAVELIEV M, LUME M, VELTHUT A, et al. Neurotrophic factors switch between two signaling pathways that trigger axon- al growth[J]. J Cell Sci, 2007, 120(Pt15) : 2507 - 2516.
9GOMEZ M, HERNANDEZ M L, PAZOS M R, et al. Coloca- lization of CB( 1 )receptors with L1 and GAP--43 in forebrain white matter regions during fetal rat brain development: Evi- dence for a role of these receptors in axonal growth and gui- dance[J]. Neuroscience, 2008, 153(3): 687-699.
10CAFFERTY W B, MCGEE A W, STRITTMATTER S M, et al. Axonal growth therapeutics: regeneration or sprouting or plasticity[J]. Trends Neurosci, 2008, 31(5): 215-220.
9Bartolomei JC, Greer CA. Olfactory ensheathing cells: bridging the gap in spinal cord injury [ J ]. Neurosurgery, 2000,47(5) :1057 - 1069.
10Nakamura M, Bregman BS. Differences in neurotrophic factor gene expression profiles between neonate and adult rat spinal cord after injury[J]. Exp Neurol, 2001,169 (2) :407 -415.
